Otonomy

Otonomy is a biotech and biopharmaceuticals company developing ear medicine and therapeutics to address unmet medical needs in the emerging otology market.

Industries

Stage

Post IPO Equity

Employees

51-200

Links

Org chart

David A. Weber
President & CEO
Collapse
Alan C. Foster
Vice President, Research
Barbara M. Finn
Vice President, Regulatory Affairs and Quality Assurance
Carla Da Luz Boren
General Counsel and Head of Human Resources
Elizabeth J. Ackermann
Vice President, Clinical Development
Fabrice Piu
Vice President, Research and Preclinical Development
Julie D. Burgess
Vice President, Finance and Administration
Paul E. Cayer
Chief Financial & Business Officer
Robert Michael Savel
Chief Technical Officer
Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.